Chemical formula: C₂₂H₂₅N₃O₇S Molecular mass: 475.515 g/mol PubChem compound: 150610
Ertapenem is indicated for:
Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)
Ertapenem is indicated in adults for the treatment of intra-abdominal infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)
Ertapenem is indicated in adults for the treatment of diabetic foot infections of the skin and soft tissue when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: women, only adolescents (12 years - 18 years old) , adults (18 years old or older)
Ertapenem is indicated in adults for the treatment of intra-abdominal infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)
Ertapenem is indicated in adults for the treatment of community acquired pneumonia when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)
Ertapenem is indicated in infants and children for the treatment of intra-abdominal infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)
Ertapenem is indicated in children for the treatment of diabetic foot infections of the skin and soft tissue when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: women, only infants (40 days - 1 year old) , children (1 year - 12 years old)
Ertapenem is children in adults for the treatment of intra-abdominal infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)
Ertapenem is indicated in children for the treatment of community acquired pneumonia when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)
Ertapenem is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Ertapenem is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
